ArticlePakistan journal of medical sciences2025
Effects of Lenvatinib combined with immune checkpoint inhibitors on efficacy, immune function and prognosis in patients with primary liver cancer.
Yuehong Hou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.